Low-molecular-weight heparin (LMWH)-loaded large porous PEG-PLGA particles for the treatment of asthma.
about
Low molecular weight heparins for current and future uses: approaches for micro- and nano-particulate delivery.Development of subcutaneous sustained release nanoparticles encapsulating low molecular weight heparin.Drug delivery to the lungs: challenges and opportunities.Sulfated non-anticoagulant heparin blocks Th2-induced asthma by modulating the IL-4/signal transducer and activator of transcription 6/Janus kinase 1 pathway
P2860
Low-molecular-weight heparin (LMWH)-loaded large porous PEG-PLGA particles for the treatment of asthma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Low-molecular-weight heparin ( ...... s for the treatment of asthma.
@en
Low-molecular-weight heparin
@nl
type
label
Low-molecular-weight heparin ( ...... s for the treatment of asthma.
@en
Low-molecular-weight heparin
@nl
prefLabel
Low-molecular-weight heparin ( ...... s for the treatment of asthma.
@en
Low-molecular-weight heparin
@nl
P2093
P2860
P356
P1476
Low-molecular-weight heparin ( ...... s for the treatment of asthma.
@en
P2093
Brijeshkumar Patel
Fakhrul Ahsan
Nilesh Gupta
P2860
P356
10.1089/JAMP.2013.1073
P577
2013-11-28T00:00:00Z